Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Operating Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Operating Profit (Excl OI) ₹2,351 Cr₹1,195 Cr₹1,635 Cr₹2,320 Cr₹2,084 Cr

What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?

The latest Operating Profit ratio of GLENMARK PHARMACEUTICALS is ₹2,351 Cr based on Mar2026 Consolidated results.
Year Operating Profit
Mar2026₹2,351 Cr
Mar2025₹1,195 Cr
Mar2024₹1,635 Cr
Mar2023₹2,320 Cr
Mar2022₹2,084 Cr

How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?

Years Operating Profit % Change
Mar2026 ₹2,351 Cr
96.71
Mar2025 ₹1,195 Cr
-26.89
Mar2024 ₹1,635 Cr
-29.53
Mar2023 ₹2,320 Cr
11.32
Mar2022 ₹2,084 Cr -

Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,639.7 Cr 1.6% 4% 15.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,675.0 Cr -3% -2.6% 21.3% Stock Analytics
DIVIS LABORATORIES ₹225,516.0 Cr -0.5% 17% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,190.0 Cr 0.6% 2.7% 35.5% Stock Analytics
CIPLA ₹115,523.0 Cr -2.2% 0.8% -2.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,493.4 Cr -1.1% -1.6% -0.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.6%

4%

15.9%

SENSEX

-1%

0.7%

-3.6%


You may also like the below Video Courses